Lupin signs MoU for TB drug research
Lupin Laboratories has signed a memorandum of understanding(MoU) with US-based Pathogenesis for research in anti-tuberculosis drugs, Mr Deshbandhu Gupta, Chairman, Lupin group, has
Lupin Laboratories has signed a memorandum of understanding(MoU) with US-based Pathogenesis for research in anti-tuberculosis drugs, Mr Deshbandhu Gupta, Chairman, Lupin group, has